Eyewire headlines are now available as a weekly podcast!
Listen Now
Eyewire News
EyewireTV
Podcast
Arrow
Topics
Events
Subscribe
Menu
Search
Eyewire News
EyewireTV
Podcast
Arrow
Topics
Events
Subscribe
Cataract
Refractive
Retina
Glaucoma
Optometry
Business
Health Care
Residents & Fellows
Cornea
Ophthalmology
EyewireTV | 05.15.2014
Now Playing
Introduction
Share
|
Copy Link
https://eyewire.news/tv/kala-pharmaceuticals
Previous EyewireTV Episodes
05.13.2026
Introduction
Future of Regenerative Medicine
Update on AI Use and Innovation
Next-Generation Therapies
Watch Episode
05.06.2026
Introduction
Bayer Expands Ophthalmology Pipeline with Acquisiton of Perfuse Therapeutics
Viridian Announces REVEAL-2 Phase 3 Data for TED Treatment Elegrobart
Steven Dell, MD, Discusses Impact of Declining Medicare Reimbursement
Watch Episode
04.29.2026
Introduction
Brent Saunders, Bausch + Lomb
Julie Brewer, Alcon
Mark Baum, Harrow
Watch Episode
04.22.2026
Introduction
Glaukos Launches Epioxa for Keratoconus; Secures J-Code
BVI Receives CE Mark for Virtuoso Phaco-Vitrectomy Surgical System
ASCRS Executive Director Recaps Annual Sightline Meeting
Watch Episode
04.15.2026
Introduction
J&J Tecnis PureSee EDOF IOL
Alcon Clareon TruPlus IOL
Oculus Pentacam Cornea OCT
Watch Episode
04.08.2026
Introduction
Massive Recall Issued for Several OTC Store-Brand Eye Drops
Dosing Intervals for Eylea HD Extended Up to Every 20 Weeks
B+L's Preloaded enVista Envy Full Range of Vision IOL Launched in Europe
Watch Episode
04.01.2026
Introduction
Biogen Enters Agreement to Acquire Apellis for $5.6 Billion
TenPoint Launches Presbyopia Drop Yuvezzi in US
Kodiak Sciences Releases Phase 3 Data on DR Drug Candidate Zenkuda
Watch Episode
03.25.2026
Introduction
2026 ASCRS Annual Meeting
Sightline Meeting Preview
Identifying Ophthalmology Trends
Watch Episode
03.18.2026
Introduction
Alcon and Lensar Terminate Proposed Merger
FDA Approves J&J's Tecnis PureSee EDOF IOL
Aldeyra Receives Third CRL for Investigational DED Drug Reproxalap
Watch Episode
03.11.2026
Introduction
Cassini Guidance System Receives Approval in Europe
NovaBridge Presents New Data for Investigational Wet AMD Therapy
Visionix VX 40 Pro Available for Pre-Sale at Vision Expo 2026
Watch Episode
03.04.2026
Introduction
Supplemental NDA of Phentolamine for Presbyopia Accepted by FDA
Eye PCR Receives CE Mark for fixOflex Endocapsular Device
Rayner Acquires US Distribution Rights to OVD Anikavisc
Watch Episode
02.25.2026
Introduction
Zeiss Releases Software App to Address Challenges in Ophthalmic Care
Oertli Launches OS 4 Up for Cataract and Vitreoretinal Surgery in Europe
Harrow Introduces PharmaPack Direct-to-Prescriber Cash-Pay Kits for Ophthalmic Medications
Watch Episode
02.18.2026
Introduction
Ocular Therapeutix Reports Positive Phase 3 Superiority Trial Results for Axpaxli for Wet AMD
Nordic Pharma Dry Eye Therapy Lacrifill Now Available in Europe
Alcon Launches TOTAL30 Multifocal for Astigmatism in US
Watch Episode
02.11.2026
Introduction
New Research Reveals Metformin May Lower Risk of AMD Progression
Study Examines Performance of Large Language Models on Ophthalmology Exams
Doctor-Led Alliance to Support Private Practice Optometrists Launches
Watch Episode
02.04.2026
Introduction
FDA Approves Yuvezzi, First Dual-Agent Eye Drop for Presbyopia
Rayner Launches AI-Powered Patient Education Platform Eyejourney
Study Examines Association Between Sleep Positioning and Eye Pressure
Watch Episode
01.28.2026
Introduction
FDA Approves NDA Supplement for Re-Administration of iDose TR
Nidek Launches Phantom Open-Field Refraction System in EU
Review of Recent Leadership Changes in Ophthalmology
Watch Episode
01.21.2026
Introduction
Rayner Receives FDA 510(k) Clearance for Sophi Phaco System
Eylea 8 mg Approved in Europe for Third Indication
Mu Medical Established After Consolidation Plan
Watch Episode
01.14.2026
Introduction
Study Reveals Widely Used Eye Injection Can Treat Hypotony
FDA Clears First Daily Disposable Soft EDOF Contact Lens for Presbyopia
Clinical Development Updates for Retinal Disease Drug Candidates
Watch Episode
01.14.2026
Introduction
Study Reveals Widely Used Eye Injection Can Treat Hypotony
FDA Clears First Daily Disposable Soft EDOF Contact Lens for Presbyopia
Clinical Development Updates for Retinal Disease Drug Candidates
Watch Episode
01.07.2026
Introduction
Merger Agreement Between Alcon and Staar Surgical Terminated
FDA Issues Another CRL to Outlook for Wet AMD Candidate
Lucentis Biosimilar Nufymco Approved by FDA
Watch Episode
12.31.2025
Introduction
July
August
September
Watch Episode
12.24.2025
Introduction
January
February
March
Watch Episode
12.17.2025
Introduction
Aldeyra Provides Updates on Timing of PDUFA Date for Reproxalap
Ocular Therapeutix to Pursue Accelerated NDA Pathway for Axpaxli
Companies with Late-Stage Drug Candidates Announce FDA Submission Plans
Watch Episode
12.10.2025
Introduction
Companies with Novel Glaucoma Technologies Reach Clinical Milestones
Haag-Streit Launches the Eyesi Indirect ROP Laser Module
EyeYon Medical to Initiate US Clinical Study of the EndoArt Corneal Implant
Watch Episode
12.03.2025
Introduction
Eylea HD Gains FDA Approval for New Indication and Dosing Schedule
Byooviz, Biosimilar to Lucentis, Approved in Europe as Pre-Filled Syringe
Phase 3 Results for Belite Bio's Stargardt Disease Drug Candidate
Watch Episode
11.26.2025
Introduction
Emerging Technologies in Glaucoma
Vialase FLIGHT Procedure
Bausch + Lomb Elios
Watch Episode
11.19.2025
Introduction
B+L Outlines Strategic Path to Innovation and Growth at Investor Day
Apellis Reports 5-Year Data Examining Syfovre and GA Progression
Two Global Organizations for Restoring Sight Merge
Watch Episode
11.11.2025
Introduction
Sydnexis and Santen Receive Approval for Myopia Treatment Ryjunea in the UK
Lilly Makes Two Deals to Acquire Investigational Gene Therapies for IRDs
Nanoscope Reports Long-Term Data for Optogenetic Therapy Candidate for RP
Watch Episode
11.05.2025
Introduction
Astellas
Apellis Pharmaceuticals
Oculis
Watch Episode
10.29.2025
Introduction
Alcon
Bausch + Lomb
Johnson & Johnson
Watch Episode
10.22.2025
Introduction
Glaukos Epioxa
Iantrek AlloFlo Uveo
Lumenis Digital Duet 2.0
Watch Episode
10.15.2025
Introduction
Uday Devgan, MD, Shares Experience Performing World’s First Robotic Cataract Surgery
Konan Medical Receives CE Mark for objectiveFIELD Analyzer
Biotech Healthcare Launches Optiflex XTENSE Comfort Plus EDOF IOL
Watch Episode
10.08.2025
Introduction
Presbyopia Eye Drop Vizz Now Commercially Available
Lumibird Introduces ICL Guru Integration for ABSolu Ultrasound Platform
Update on Gene Therapy Candidates for Retinal Diseases
Watch Episode
10.01.2025
Introduction
Iantrek
PLU Ophthalmic
SpyGlass Pharma
Watch Episode
09.24.2025
Introduction
Amaros
Atia Vision
Aurion Biotech
Watch Episode
09.17.2025
Introduction
Roche Contivue with Susvimo
Alcon Product Launches
Glaukos iStent infinite
Watch Episode
09.10.2025
Introduction
Purpose of National Eye Institute
NEI Contributions
Impact of NEI Consolidation
Watch Episode
09.03.2025
Introduction
Clinical Updates of Investigational Treatments for Retinal Diseases
Nicox Provides Phase 3 Results for Investigational Glaucoma Eye Drop
First-in-Human Implantation of Ocumetics Lens Accommodating IOL
Watch Episode
08.27.2025
Introduction
Ciliatech Obtains CE Certification for Intercil Uveal Spacer for Glaucoma
Zeiss Receives CE Mark for Cirrus PathFinder AI Tool with Automated OCT Assessment
FDA Provides Update on Target Action Dates of Two Eylea HD Submissions
Watch Episode
08.20.2025
Introduction
Goals of the TFOS DEWS III Report
Treatment Algorithms
Collaborative Effort
Watch Episode
08.13.2025
Introduction
Charles Wykoff, MD, Shares Experience Performing First Commercial Surgeries for MacTel
VSY Biotechnology Launches Enova Hydrophobic IOLs with the Rotary jet Delivery System
Altris Sync App Allows to AI to Sync Directly to OCT Devices
Watch Episode
08.06.2025
Introduction
Alcon Boosts Refractive Portfolio with Acquisition of Staar Surgical
Lenz Therapeutics CEO Discusses FDA Approval of Vizz Presbyopia Drop
Optical Industry Braces for Changes as New Reciprocal Tariffs Begin
Watch Episode
07.30.2025
Introduction
Alcon Announces US Commercial Availability of Tryptyr for Dry Eye Disease
Boehringer Ingelheim and Re-Vana Therapeutics Enter $1B Collaboration
Companies with AMD Drug Candidates Complete Phase 3 Enrollment
Watch Episode
07.30.2025
Introduction
Alcon Announces US Commercial Availability of Tryptyr for Dry Eye Disease
Boehringer Ingelheim and Re-Vana Therapeutics Enter $1B Collaboration
Companies with AMD Drug Candidates Complete Phase 3 Enrollment
Watch Episode
07.23.2025
Introduction
Harrow Adds Biosimilars to Portfolio After Deal with Samsung Bioepis
Nanoscope Initiates Rolling Submission of Gene Therapy for RP
FDA Accepts Aldeyra's Resubmitted NDA for Reproxalap
Watch Episode
07.16.2025
Introduction
AECOS Summer Symposium
Kendall Donaldson, MD
Cathleen McCabe, MD
Watch Episode
07.09.2025
Introduction
Alcon Acquires LumiThera, Maker of PBM Device for Dry AMD
European Commission Approves Eylea 8 mg for Extended Treatment Intervals
Myopia Management: The Business of Ophthalmology or Optometry?
Watch Episode
07.02.2025
Introduction
Glaukos Receives EU Certification for Several MIGS Technologies
Phase 3 Data Presented for Phentolamine Solution for Presbyopia
J&J Launches Acuvue Oasys Max 1-Day Multifocal for Astigmatism, Contact Lens
Watch Episode
06.25.2025
Introduction
Special Report: Update on Holland Foundation
Update on Mission of Holland Foundation
Recent Accomplishments
Watch Episode
06.18.2025
Introduction
TFOS DEWS III Report Explores Diagnosis and Management of DED
J&J Launches Tecnis Odyssey IOL in Europe, Middle East, and Canada
Harrow Acquires US Commercial Rights to Byqlovi
Watch Episode
06.11.2025
Introduction
Ryjunea, First Pharmaceutical Treatment for Myopia, Approved in Europe
FDA Accepts Tenpoint Therapeutics’ NDA for Brimochol PF for Presbyopia
Reimbursement Landscape in Ophthalmology
Watch Episode
06.04.2025
Introduction
FDA Approves Alcon's Tryptyr for Signs and Symptoms of DED
FDA Expands Label for Genentech's Susvimo Implant to Include DR
Investigational Wet AMD Treatments Complete Enrollment in Phase 3 Trials
Watch Episode
06.04.2025
Introduction
FDA Approves Alcon's Tryptyr for Signs and Symptoms of DED
FDA Expands Label for Genentech's Susvimo Implant to Include DR
Investigational Wet AMD Treatments Complete Enrollment in Phase 3 Trials
Watch Episode
05.27.2025
Introduction
Executives Share Their Experience Overcoming Challenges
Bausch + Lomb
Alcon
Watch Episode
05.21.2025
Introduction
B+L Launches Zenlens CHROMA HOA Scleral Contact Lenses in the US
New World Medical Introduces Enhanced Streamline Surgical System
Intalight Receives CE Mark for DREAM OCT Platform
Watch Episode
View More
Share
Copy Link
Eyewire headlines are now available as a weekly podcast! Listen Now ShareCopy Link
